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Abstract 
In this paper, we reanalyze Medical Innovation, the 
classic study on diffusion of a new drug Tetracycline, 
by Coleman, Katz and Menzel (1966). Medical 
Innovation and the subsequent reanalyzes of the 
original data failed to capture the complexity of events 
involved in the diffusion process. In this paper, for the 
first time, we address this limitation by combining 
Agent-Based Modelling (ABM) and network analysis. 
Based on the findings of Coleman et. al. (1966) study, 
we develop a diffusion model, Gammanym, in which 
Doctors’ adoption thresholds are decremented by 
information from their social and professional 
networks as well as pharmaceutical company supplying 
Tetracycline. The cumulative adoption curves are 
derived for three sets of initial conditions, based on 
which network topology and evolution of uptake are 
analyzed. Averaged over an ensemble of 100 runs, 
clustering coefficient and average shortest path length 
indicate that social networks depicted in Gammanym 
are random graphs. Evolution of uptake suggests that 
although the degree of external influence in terms of 
marketing strategies adopted by the pharmaceutical 
company does not have impact on the network 
structure, the speed of diffusion is largely determined 
by it. 
SECTION 1: Introduction 
In this paper we reanalyze Medical Innovation by 
Coleman, Katz and Menzel (1966), the classic study on 
diffusion of Tetracycline, which at that time was a 
newly introduced antibiotic. Their pioneering study 
elaborated on how different patterns of interpersonal 
communications can influence the diffusion of a 
medical innovation in four medical communities in 
Illinois.  
The motivation for our reanalysis is to capture the 
complex interactions involved in the diffusion process 
by combining Agent-based Modelling (ABM) and 
network analysis. Based on the findings in Medical 
Innovation, we develop a diffusion model called 
Gammanym. The topology of networks generated in 
Gammanym, and its evolution, are analyzed to evaluate 
how, and to what extent, network structure influences 
the diffusion process.  
We describe the original study and the rationale for our 
study in the following section. Section 3 describes the 
modelling framework, modelling sequences and 
methods. Simulation results under different scenarios 
are analysed in Section 4. The structure of the social 
networks depicted in our model, and its evolution are 
analysed in Section 5. The paper concludes with 
discussions and a review of the implications of the 
simulation results. 
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SECTION 2: Diffusion and 
Networks 
2.1 Diffusion of Tetracycline 
Tetracycline was launched in November 1953. The 
success of its release was uncertain for the 
pharmaceutical companies because of an already 
established market for broad-spectrum antibiotics. Four 
US Midwestern cities: Peoria, Bloomington, Quincy 
and Galesburg, were selected for the original study.  
The authors wanted to set the study in a group of three 
or four cities in one contiguous area that was not in the 
shadow of a large medical centre, but where the cities 
differed from each other in terms of available hospital 
facilities: the number of teaching hospitals and general 
hospitals and population. The sample constituted 148 
general practitioners, internists, and paediatricians in 
active practice, of which 126 (85% of the sample) were 
interviewed. In an attempt to evaluate the importance 
of social networks, each of them was asked about their 
close associates (e.g., friends, colleagues and advisors) 
in the medical community. In order to measure the time 
of adoption, a prescription audit in the local pharmacies 
were carried out for 125 doctors (121 general 
practitioners, internists, and paediatricians and 4, listed 
as surgeons or proctologists) over a 16-month period 
following the release of Tetracycline for general sale. 
Prescriptions were edited for three successive days at 
approximately monthly intervals (Coleman, Katz and 
Menzel 1966: 194). 
In our analysis of the Coleman et. al. study, we identify 
two broad categories of variables influencing the 
diffusion process. The first category represents 
personal traits or individual variables, affecting 
individual receptivity.  Individual variables, based on 
which innovators or early-adopters of Tetracycline are: 
1. type of practice, 2. medical background, 3. contacts 
with out-of-town institutions, 4. media behaviour, and 
5. orientations and attitudes. The second category 
defines social variables influencing the adoption 
process as a result of social or professional ties to other 
members of the community.  The influences of 
professional networks were evaluated on the basis of 
four factors that enable exchange of information in 
professional settings: 1. hospital affiliation, 2. shared 
office, 3. advice seeking, and 4. discussion. The 
friendship structure, on the other hand, emerged from 
the informal discussion among doctors in a social 
setting and doctors were asked to name three doctors 
whom they see most often socially.  
The study revealed strong evidence for social 
contagion, i.e. doctors’ decisions to adopt Tetracycline 
were strongly influenced by the people they are 
connected to either socially or professionally. It 
appeared that the integrated doctors differed very little 
from their isolated colleagues at the beginning of the 
introduction of Tetracycline, but their rate of adoption 
accelerated to produce an increasing gap between 
‘integrated’ and  ‘isolated’ doctors (Coleman, Katz and 
Menzel 1966). 
2.2 Social Contagion vs. Media Exposure 
We want to verify if the diffusion process depicted in 
the original study is better captured by ABM, and also 
analyze the network structure governing the adoption 
of new drug.  
Burt (1987) used Coleman et al. (1966) study to derive 
three major conclusions: 1. where contagion occurred, 
its effect was through structural equivalencei not 
cohesion; 2. regardless of contagion, adoption was 
strongly determined a physician’s personal preferences, 
but these preferences did not dampen or enhance 
contagion; 3. there was no evidence of a physician’s 
network position influencing adoption when contagion 
is properly specified in terms of structural equivalence.  
Strang and Tuma (1993) apply an event-history 
framework at the Coleman et al. (1966) data to analyze 
a class of diffusion models incorporating spatial and 
temporal heterogeneity.  Their result contradicts Burt, 
as their models indicate that, “Contagion in medical 
innovation is not a simple product of structural 
equivalence. Cohesive ties based on advice giving and 
discussion also contribute to diffusion, as do structures 
of similarity in physicians’ orientation towards their 
work (Strang and Tuma 1993: 638).” 
Valente (1995) tests his threshold/critical mass (T/CM) 
model on medical innovation data. The T/CM model 
requires a threshold measure and a determination of the 
critical mass, a system level measure of the minimum 
number of participants needed to sustain a diffusion 
process (Valente 1995: 79). The study indicates that the 
opinion leaders, who have greater exposure to external 
influence, play a dominant role in the diffusion 
process. A study by Van den Bulte and Lilien (2001)  
provides strong support for external influence in the 
diffusion of tetracycline by incorporating a data set  on 
advertisement volume. As the empirical results were 
unable to detect statistically significant contagion 
effect once advertising effect is controlled for, the 
authors conclude that the data do not show that 
diffusion was driven by contagion operating over social 
networks, and that earlier analyses confounded social 
contagion with the effect of marketing effort (Van den 
Bulte and Lilien 2001).  
2.3 Rationale for Gammanym 
We reanalyze the medical innovation study by applying 
ABM for two principal reasons: non-inclusion of 
dynamics of network structure and complexity in any 
of the previous studies, and a limited exploration of the 
impact of external influence or media exposure from   
previous reanalyses of the Coleman et al. (1966) data. 
The major limitation of all the previous studies is their 
static exposition of network structure, which falls short 
of representing the evolving process. These dynamics 
can be described by the ‘Dynamics of the network’, or 
the evolving structure of the network itself such as the 
making and breaking of network ties. The other set of 
dynamics refers to ‘Dynamics on the network’, created 
due to the actions taken by individuals.  The outcome 
of their individual actions is influenced by what their 
neighbors are doing and, therefore, the structure of the 
network. In the real world, both kinds of dynamics 
exist simultaneously (Watts 2003). Until now, 
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however, neither medical innovation study nor the 
subsequent reanalyses of the original dataset 
incorporated any of those dynamic features. Our study 
therefore complements the extant work.  
Our study also makes contribution in that the 
complexity generated in the diffusion process has not 
been examined by any previous studies. In Medical 
Innovation, the extent of influence was evaluated for 
pairs of individuals.  Individual network (discussion, 
friendship or advice) was, therefore, perceived as a set 
of discrete/disjointed pairs. Given the existence of 
overlapping networks and consequent influences on 
doctors’ adoption decisions, the complexity of actual 
events can not be captured by pair analysis. Indeed, the 
authors themselves considered that analyzing in pairs 
was the major limitation of the studyii.  ABM enables 
us to address this limitation in previous studies by 
considering the whole network as a unit of analysis. 
Apart from the study by Van den Bulte and Lilien 
(2001), external influence in the diffusion process has 
also not been analyzed rigorously for the medical 
innovation data set. External influence is created from 
different forms of advertising and intensive coverage 
by representatives from the drug companies. In the 
medical innovation study, doctors acknowledged that a 
‘detailman’ or a pharmaceutical representative, and 
also direct mail from the drug companies, as the major 
source of initial information about Tetracycline. The 
original study however did not contain any information 
on marketing effort by drug companies. An attempt to 
collect data on marketing effort was constrained by the 
fact that back issues of Journal of American Medical 
Association (JAMA) did not have any advertising 
supplement, as they were removed before binding for 
storage (Van den Bulte and Lilien 1999). In our study, 
we examine the impact of external or media influence 
by performing sensitivity analysis. The simulation 
results allow us to explore the behaviour of the 
pharmaceutical companies, which has not been 
examined in a MAS (Multi-Agent System) setting. 
SECTION 3: Modelling Framework 
Using SMALLTALK programming language, we 
develop Gammanym with the CORMAS platform 
(Common-pool Resources and Multi-Agent Systems, 
http://cormas.cirad.fr) under Visual Works 
environment. 
3.1 Spatial Representation and Passive Objects 
We portray the medical community in an 8 X 8 spatial 
grid. The unit cell captures three different locations for 
professional interactions: Hospitals, Practices and 
Conference Centre, which are created as Passive 
objects. Gammanym has sixty-one practices, two 
hospitals and one conference centre, randomly located 
over the spatial grid. In the original study, on average 
47% of doctors were alone in office, 20% were in 
clinics, 17% were working with two colleagues and 
15% were sharing office with one colleague. We 
captured the categories of office partnership into three 
practice typesiii; Private (alone in office), Center 
(shared office with two partners) and Clinic (working 
with four colleagues). The doctors in Gammanym 
model are thus distributed among 46 private, 11 centers 
and 4 clinics. 
Gammanym specifies two hospitals, as all the cities, on 
average, have two hospitals. Conference centre, the 
third passive entity, provides the context in which a 
much larger group of professionals can interact with 
each other. Planning captures the time steps for three 
conferences, either randomly chosen by the model or 
specified by the modeler. Random allocation of these 
practices over the grid reflects that spatial 
representation is not sensitive to distances. In other 
words, the doctors’ decision to go to hospitals or the 
conference centre, do not depend on the location of 
their practices; as the grid does not incorporate any 
Geographic Information System (GIS) specifications. 
Their inclusion was not possible, as we do not have the 
original data set. GIS specifications, on the other hand, 
would add little to our analysis in the sense that the 
significance of physical distance in diffusing a new 
idea/knowledge can, and is, well captured by our 
definition of discussion networks. Without GIS 
specifications real distance between cells have no 
impact on the doctors’ decision to move from office to 
hospitals or conference centers. An 8 x 8 spatial grid, 
therefore, is considered succinct to represent the 
medical community depicted in the original study.   
3.1.2. Social agents  
Gammanym depicts two kinds of social agents- Doctor 
and Laboratory. Initially located in their respective 
practices, Gammanym creates 99 doctors, the principal 
agents in the diffusion process. A laboratory, on the 
other hand, influences doctors’ adoption decisions by 
sending information through multiple channels: 
medical representatives, journals and commercial 
flyers.  
3.1.2.1 Located and Communicating Agents: 
Doctors 
In Gammanym, Doctors are specified with the 
attributes generating network effects only. Individual 
traits have impacts on the adoption decision. 
Nevertheless, we opt for this simplification on the basis 
of the correlation coefficient estimated in medical 
innovation. Four network variables, shared office, 
advice seeking, discussion and friendship, showed a 
strong association to the date of first use of 
Tetracycline than any other individual variables, with 
the single exception of total volume of prescriptions for 
the class of drugs. Holding the volume of prescriptions 
constant, the association between integration and 
adoption increased (Coleman, Katz and Menzel 1966: 
92). Thus, we explore if all the doctors are 
homogenous in terms of their individual attributes or 
‘degree of predisposition to adoption’ (Burt 1987), to 
what extent does integration matter for adoption 
decision? In our model, a random friendship network 
and professional networks are created through 
discussions with office colleagues, or through hospital 
visits or conference attendance, or all of the above.  
 The friendship network is random in nature as the 
doctors are initialized with random number of friends 
and counter for friends; both ranging from 0-3. In the 
original study, indices of similarityiv of pairs were 
analyzed in order to identify the attributes the doctors 
share with the colleagues they choose as friends, 
discussion partners or advisors. We treated the indices 
with reservation, because of their limited statistical 
relevance with only 111 friendship pairs (Coleman, 
Katz and Menzel 1966: 143).  
Professional interactions are spatially defined, based on 
which Gammanym builds discussion networksv. We do 
this to signify the importance of tacit knowledge or 
non-codified knowledge, which requires face-to-face 
contacts for its transmission. The doctors, therefore, 
consider the others as discussion partners if they are 
situated in the same cell. Office partnership is central 
to professional networks as the doctors made most of 
their interactions in their practices.  After each visit to 
hospital or conference centers, doctors return back to 
their practices.  
3.1.2.2 Communicating Agents: Laboratory 
In Gammanym, we incorporate one pharmaceutical 
company as a communicating social agent, termed the 
Laboratory (LAB from hereon). LAB adopts a mixed 
marketing strategy with three different channels to send 
information about the new drug:  
i. Detailman (pharmaceutical representative) 
visiting practices; 
ii. Flyers, available at the conferences; 
iii. Journals, sent to doctors’ practices. 
57% of the doctors asked to reconstruct their stages of 
diffusion, identified detailman as the first source of 
information. Hence, we opt for a blanket exposure of 
all doctors to detailman. In Gammanym the detailman 
visits all the doctors at their practices. In the original 
study, drug house mails or direct mail advertising was 
identified as the second major source of information. 
Assuming similar influences by direct mail advertising 
and journal insertions, we specify journals as the 
second option for the LAB.  
Without prior specification in any of the previous 
studies, we introduce flyers at the conference centers. 
From the perspective of the LAB, inclusion of flyers is 
crucial as it adds another dimension to the marketing 
mix by targeting a large group of doctors at the same 
time. To avoid the notion of blanket exposure to all 
doctors, we specify the criterion that LAB sends flyers 
based on the number of previous conference 
participants. 
3.4 Adoption Process/Decision-making process 
Doctors’ decisions to adopt a new drug involve 
interdependent local interactions among different 
entities in Gammanym. Diffusion scholars have long 
recognized that individual’s decision about adoption is 
a process that occurs over time, consisting of several 
stages (Coleman, Katz and Menzel 1966;Rogers 1995). 
We specify five stages of adoption: 1. Awareness or 
knowledge,  2. Interest, 3. Evaluation/mental trial, 4. 
Trial, and 5. Adoption/acceptance. In our model 
readiness is specified as the attribute signifying the 
above stages of adoption. All doctors are initialized 
with readiness 4. Readiness is decremented when they 
receive an alert from different sources.  
Discussions with other doctors, either friends or 
colleagues at practices, conferences, or hospitals 
generate an alert when the mean adoption rate is 0.50 
or above. In case of the LAB, on the other hand, an 
alert is created each time a doctor received information 
from the detailman, flyers or journals. Doctors’ 
readiness is gradually reduced with alerts from all the 
aforementioned sources. When the readiness reaches 
zero (Adoption/acceptance stage), doctors adopt the 
new drug. 
3.5 Modelling Sequence 
Gammanym is divided into four phases: i) managing 
professional interactions; ii) external influence; iii) 
decision making process; and iv) networks formation. 
At each time step, Gammanym resets the attributes of 
the practices. Thus, the doctors are at their respective 
practices at the beginning of each simulation. 
Phase I entails the methods for doctors’ professional 
interactions. Primarily, the doctors interact with the 
office colleagues at their practices. Hospitals are 
another location for professional interactions, where 
they have their monthly visits. The third location for 
information exchange is the conference centre, as the 
doctors move from their practices to there after 
receiving invitations. Phase II depicts the mixed 
marketing strategy adopted by the LAB. At each time 
step, the LAB targets practices from the unvisited ones 
and send the detailman if the doctors are available. 
After receiving an invitation for a conference from the 
conference center, the LAB sends flyers to the 
conference centre based on number of previous 
conference attendees. Journals are incorporated in 
Gammanym as the third strategy. LAB issues journals 
only when the number of newly adopted doctors in the 
previous time step, i.e., the last increment, is less than 
half of the average number of adopted doctors. Phase 
III is the decision-making process based on readiness. 
Phase IV constitutes the methods for network 
formation. At each time step, the network matrices for 
professional networks and friendship networks contain 
the number of interpersonal interactions for each 
doctor. The adoption matrix, on the other hand, 
specifies the adoption status at each time step for all 
the doctors.  
 
SECTION 4: Simulation Results  
In this section our discussion traces through the shape 
of the cumulative diffusion curves under three 
scenarios. The three scenarios are specified to evaluate 
the degree of influences by different factors in the 
diffusion process:  
1. Baseline Scenario; with one ‘seed’ or initial 
adopter, one detailman and one journal ; 
2. Heavy Media Scenario; with one initial 
adopter but different degrees of external 
influence, by increasing the number of 
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 detailman to five and the number of journals 
to four ; 
3. Integration Scenario; one initial adopter, 
without any external influence from the LAB. 
All three scenarios have been run over a 68 weeks or 
17 months which was the time length for original 
study. As several random functions are included in the 
algorithm, each scenario is repeated 100 times in order 
to estimate the output’s variability. For each of the 
cases, the seed or the innovator is chosen among the 
doctors who are practicing at centers, i.e. doctors who 
have two colleagues.  
The cumulative diffusion curve (CDC), representing 
the total number of adopted doctors at each time step is 
shown in Figure 1. All three curves are derived after 
averaging over 100 simulations.  
Baseline scenario (Figure 1: Series 1) with one 
innovator and one detailman generated a logistic or S-
shaped curve, similar to those found in cases of mixed 
influence diffusion models (Ryan and Gross 1943; 
Mahajan and Peterson 1985; Rogers 1995; Valente 
1993). In this scenario, our model reveals an adoption 
curve with an initial phase of slow diffusion until the 
first inflection point at the 24-time step where 23% of 
doctors have adopted the new drug. Thereafter, the rate 
of adoption speeds up as more doctors are exposed to 
someone who has already adopted and gradually begins 
to level off as fewer doctors remain in the population 
who are yet to adopt. Overall, 92% of doctors adopted 
the new drug by the end of 48 weeks, or within 12 
months. With one innovator in the system, diffusion 
seeds through the system as the doctors’ adoption 
decisions are simultaneously influenced by their 
exposure to the new drug through actions by LAB as 
well as interpersonal communication. 
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The steepest diffusion curve (Figure 1: Series 2) 
represents a heavy media scenario, where 50% of the 
population adopts the new drug at the end of 12 weeks. 
The rate of diffusion increases up to 16 time steps and 
decreases afterwards as only 18% of doctors at that 
time have failed to adopt and remain unaffected. At the 
25 time step, the CDC levels off as all the doctors have 
adopted the new drug. 
 The integration scenario represents an extremely slow 
diffusion process (Figure 1: Series 3). As the only 
means to have an alert is to be in contact with the 
initial adopter, only 18% of the population adopt the 
new innovation at the end of 68 time steps. 
SECTION 5: Network Analysis 
In this section we will examine: (1) the topology of the 
interaction networks that are generated by the agent 
based simulations; (2) how the networks evolve over 
time; and (3) the way the uptake evolves across these 
networks.  
5.1. Network Topology 
We first calculate the degree distribution to identify the 
class of networks the ABM interaction networks from 
four possible alternatives: (1) regular lattices; (2) 
random graphs (Erdös and Rényi 1959) (3) small world 
networks (Watts and Strogatz 1998); and (4) scale-free 
networks (Barabási 2002). Our simulations produce a 
degree distribution (Figure 2) that conforms to a 
binomial distribution, which suggests that the networks 
are most likely either a random graph, or a small world 
network (Watts 1999). 
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Figure 1: Cumulative Diffusion Curves for three scenarios: Baseline( Series 1), Heavy Media( Series 2) and 
Integration ( Series 3) 
 Many social systems display two statistical properties; 
first they display a high degree of clustering when 
compared to random graphs; second they have an 
average shortest path-length similar to that found in 
random graphs.  These two properties are known as the 
small-world properties.  The clustering coefficient 
(CC) is a measure of the number of friends of friends 
type relationships found within the network. For a 
given node , with  neighbors,  is defined to be 
number of links between the  neighbors.  The 
clustering coefficient is the ratio between 
the number of links that exist between 
neighbors ( ) and the potential number 
of links 
iN ik iE
ik
iE
( )( )
2
1−ii kk  between the neighbors.  
The average clustering coefficient is: 
Figure 2: Degree distribution created of the interaction networks in 
Gammanym 
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The average shortest path length (PL) is 
defined as: 
 ( )j
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∑∑
= +=−=
N
i
N
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1
, 
where PLmin is the minimum distance 
between nodes i and j. 
A network is said to have small world 
properties if, compared to an Erdös-Rényi 
random graph, the following conditions 
hold: randPL≈ and . 
The comparison between the interaction 
networks generated by the simulation 
model, and an ensemble of random graphs 
reveals that  and 
randCC>>CC
modelPL randPL≈
randmodel CCCC ≈ .  This suggests that the 
networks depicted in Gammanym are 
random graphs.  
 
5.2 Evolution of Networks 
 
The evolution of social networks in 
Gammanym can be analyzed to gain an 
understanding of the diffusion process. As 
agents interact with each other, new 
connections (relationships) form between 
agents, while others are reinforced. Figure 
3 shows the evolution of connectivity 
between agents within the simulation. The 
connectivity is defined as )1( −NNL , where 
L  is the total number of interactions 
within the system and  is the total 
number of agents within the simulation.  
Connectivity values were averaged over an 
ensemble of 100 runs. From Figure 3, it 
can be seen that the connectivity within the 
system grows as a function of n log n over 
time. An interesting property in Figure 3, 
are the sudden jumps in connectivity 
associated with conference events.  The 
most notable of these occurs at time step 55 and 
appears to capture an element of many real world  
‘networking’ events, where people come together to 
exchange ideas and experiences.  
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Initially the agents are only connected to doctors that 
they interact with, within their practices. This means 
that system consists of a set of disconnected groups of 
agents or clustersvi. This means that the flow of 
information within the system is limited to only small 
isolated pockets of interactions.  However, as 
 
Figure 3. Evolution of connectivity within  professional and friendship 
networks. 
 connectivity increases, the size and the nature of these 
clusters changes. 
In order to study the nature and structure of clusters, 
we define a cluster as a set of agents that are connected.  
That is, there exists a path from any agent to any other 
agent within that cluster. At each time step within the 
simulation we count the number of groups of agents 
and calculate the maximum, minimum, average cluster 
size, standard deviation in cluster size and the average 
shortest path length between agents within the system. 
All statistics were averaged over an ensemble of 100 
runs. Figure 4 shows how the clusters of agents evolve 
over time.  
From Figure 4, we see that initially the simulation 
contains approximately 60 clusters of agents (Figure 
4A).  As new interactions occur, the number of clusters 
quickly decays. Similarly, the maximum cluster size 
grows rapidly (Figure 4 B).  The minimum and average 
cluster sizes quickly explode as the agents become 
consumed by the giant cluster (Figures 4 (C–D)). The 
system begins to behave as one giant cluster after about 
7–10 time steps. The standard deviation in cluster size 
is maximized just before the emergence of a fully 
connected system (Figure 4E). We note that the 
average shortest path length between nodes initially 
increases rapidly, as more and more nodes become 
connected to the giant cluster. When the system 
becomes connected, such that there exists a path 
between all agents, the average shortest path-length 
between any two nodes is on average is relatively long. 
This is because of the sparsity of interaction matrices 
and the network containing many long paths.  
However, as the system increases in connectivity the 
path-lengths become smaller until there is 
approximately two degrees of separation between any 
two agents within the system (Figure 4F). In short, the 
system initially consists of a number of disconnected 
components, but quickly evolves to form a single 
connected component.  The size and structure of these 
clusters define how far and how quickly Tetracycline is 
adopted. 
5.3 Evolution of Uptake 
To analyze 
the 
differences 
in the speed 
of diffusion 
depicted in 
Section 4.1, 
we can look 
at how 
Tetracycline 
uptake 
evolves 
under three 
scenarios. 
We, 
therefore, 
define an 
uptake 
cluster as a 
set of agents 
who are 
connected to 
each other 
and each 
agent has 
adopted 
Tetracycline
. In this 
context the 
uptake 
cluster can 
be thought 
of as a cluster commonly encountered in percolation 
studies (Stauffer 1979). Figure 5 shows how the uptake 
of Tetracycline evolves through time. 
 
Figure 4: Network statistics. (A) Number of clusters; (B) Maximum cluster size; (C) Minimum cluster 
size; (D) Average cluster size; (E) Standard deviation in cluster size; (F) Average shortest path-length. 
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In the base scenario, starting from one seed (innovator) 
the average number of uptake clusters increases up to 
1.6 at time step 15 (Figure 5A). Then, it decreases to 
one giant cluster (time step 30) as the size of the 
existing clusters increases gradually before merging. In 
Figure 5 (A) we also observe that the number of uptake 
clusters explodes rapidly under the heavy media 
scenario (Figure 5A).  
 
Compared to the base scenario, much faster dynamics 
is displayed with the giant uptake cluster forming at 
time step 15 with heavy media exposure. At time step 
20, 100% of the doctors have adopted the drug and the 
size of the uptake cluster equals the size of the social 
network.  
The integration scenario displays a very slow process 
of diffusion. On average, only one uptake cluster forms 
during the 68 time steps, and its maximum size barely 
reaches 20 by the end of the simulation (Figure 5B). 
Thus, despite a very efficient deployment of the giant 
social cluster, the uptake cluster struggles to invade the 
whole network without external influence. 
SECTION 6: Concluding Remarks 
We develop an agent based model, called Gammanym, 
to analyze the diffusion process. This is inspired by the 
classic Medical Innovation study on the adoption of 
Tetracycline in the Midwestern US in 1950s by 
Coleman, Katz and Menzel (1966). Due to the limited 
availability of proper technique/methods during 1950s, 
the original study focused on interpersonal influence 
for pairs of individuals. This approach, however, fails 
to capture the complexity and dynamics of actual 
adoption. In our study, we overcome this limitation 
using agent-based modelling to consider the whole 
network as a unit of analysis. Our model brings 
original features within the existing literature of 
diffusion research and also complements the extant 
work on medical innovation. 
In our study we also examine the diffusion process by 
applying the core concepts of network theory. Network 
properties like connectivity, clustering, degree 
distribution and others, are estimated from the 
interaction matrices generated by agent-based model. 
On the basis of these properties we determine that the 
interaction networks depicted in the model are random 
graphs. Complexity of the diffusion process is 
Figure 5:  Uptake clusters for three scenarios (A) Number of clusters within the system; (B) Maximum cluster size; 
(C) Minimum cluster size; (D) Average cluster size; and (E) Standard deviation of cluster size. 
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explained by analyzing evolution of networks or 
dynamics on the networks. We find that initially the 
system consisted of a number of disconnected 
components and quickly evolves, after 7-10 time steps, 
to form a single connected component. The analysis of 
network topology also indicates that underlying 
networks evolve in predictable ways, and the uptake is 
a function of the initial starting condition.  
Analysis of the evolution of uptake or adoption of 
Tetracycline enables us to disentangle the extent of 
different factors affecting adoption. Despite stressing 
the complementarity between network theory and 
diffusion research, a large body of diffusion literature 
has so far failed to examine the dynamic structures of 
the interpersonal networks and their evolutions over the 
diffusion process. Our model shows that although the 
media does not influence the network structure, it does 
have a major impact in accelerating the diffusion 
process.  Under a heavy media exposure undertaken by 
the pharmaceutical company to increase sale of 
Tetracycline, the average size of clusters with agents 
who have adopted the new drug rise faster than 
otherwise. Moreover, all the agents adopt the new drug 
within 25 time steps, a much earlier than that with a 
baseline scenario with much less media exposure. We 
validate the previous evidence of a dominant media 
influence by comparing the speed of diffusion for three 
scenarios: baseline, heavy media and integration. The 
dominant role of media also suggests there is a trade 
off between the effort expended in promoting a new 
drug, and the speed of the diffusion process. 
We also compare the cumulative diffusion curves of 
Gammanym with those of medical innovation. The 
cumulative diffusion curve under the heavy media 
scenario with initial speedy diffusion resembles more 
the one in the original study, compared to that of the 
typical S-shaped diffusion curve generated under 
baseline scenario or mixed influence diffusion. To 
summarize, our results provide support to the 
importance of social networks in the diffusion process, 
but also show that external influences play a dominant 
role in speeding up the rate of adoption. 
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i Structural equivalence is the degree two individuals 
occupy the same position in a social system. A 
structural equivalence model of diffusion postulates 
that individuals are influenced to adopt an innovation 
by imitating the behaviour of others to whom they are 
structurally equivalent.  
 
ii “To analyse pairs of individuals instead of single 
individuals may seem like only a very modest step 
towards the analysis of networks of social relations. It 
would be more satisfactory, and truer to the complexity 
of actual events, if it were possible to use longer chains 
and more ramified systems of social relations as the 
units of analysis. But so little developed are the 
methods for the analysis of social processes, that it 
seemed best to be content with the analysis of pair 
relationships”, so writes the authors themselves 
(Coleman et. al. 1966:114). 
 
iii Elaborating on significance of office partnership to 
generate network effects, the researchers in the original 
study specified it’s three broad categories (Coleman et. 
al. 1966: 73): alone in office, shared office, clinic. 
Shared office was further classified on the basis of 
number of colleagues being one, two, and three or 
more. Shared office for three or more colleagues are 
not incorporated as only 3 doctors in City B was 
identified for this category. We specified 5 doctors to 
be practiced in a clinic based on the representation of 
office partnership in City D (Coleman et. al. 1966: 
Figure 15). Majority of doctors in City A were 
practicing alone (53%); in contrast to which 50% of 
doctors were affiliated with clinics in City C. None of 
the doctors in City B were practicing in a clinic. See 
Medical innovation (P 73-74) for detailed analysis. 
iv The index varies from a value of +1, where all 
doctors choose others like themselves, to -1, where 
doctors choose only others who are unlike themselves. 
Based on the indices of similarity (in parenthesis for 
each factor), the order of importance for choosing 
friends were: religion (0.403), professional age (0.195), 
place of growing up (0.146) and medical school 
(0.167). 
 
v Our intension to distinguish among discussion and 
advice networks was constrained, primarily, by 
unavailability of original data. The criteria for advice 
networks, was further complicated by the fact that none 
of the common background factors seemed to work for 
choosing the advisor, as the indices of similarity for 
religion, professional age, place of growing up and 
medical school are respectively 0.109, 0.042, 0.077, 
0.018. Interestingly enough, analyses by Burt (1987) 
and Stang and Tuma (1993), despite using the original 
dataset, were not specific in distinguishing the 
structures of those two networks either. 
 
vi This type of clustering is not to be confused with the 
structural clustering measured by the clustering 
coefficient. Clusters in this context, simply refers to a 
connected group of nodes. 
